Enhancing hypertension detection and control through a hypertension certification program for pharmacists: A cluster randomized trial (The R x PATH Study).

Most educational programs are not evaluated at the patient care level. The HC-PCP taken by pharmacists resulted in a 4.76 mmHg systolic BP reduction in their patients over 3 months. This would have major implications for public health, reducing heart disease, stroke and kidney failure.